Stocks and Investing Stocks and Investing
Thu, January 3, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
ROST SqueezeTrigger Price is $57.05. There is $263,086,560 That Short Sellers Still Need To Cover.
[ Thu, Jan 03rd 2013 ] - WOPRAI
EOC SqueezeTrigger Price is $49.37. There is $11,806,600 That Short Sellers Still Need To Cover.
[ Thu, Jan 03rd 2013 ] - WOPRAI
MCY SqueezeTrigger Price is $40.65. There is $22,882,500 That Short Sellers Still Need To Cover.
[ Thu, Jan 03rd 2013 ] - WOPRAI
TBIO, Removed From Naked Short Lists Today
[ Thu, Jan 03rd 2013 ] - WOPRAI
CYCC, Has Remained On Naked Short Lists 13 Consecutive Days
[ Thu, Jan 03rd 2013 ] - WOPRAI
HRTPY, Added To Naked Short Lists Today
[ Thu, Jan 03rd 2013 ] - WOPRAI
LKFN, CKEC, Expected to Trade Higher After Bullish Insider Trading
[ Thu, Jan 03rd 2013 ] - Market Wire
Orvana Reports Fiscal 2012 Conference Call Details
[ Thu, Jan 03rd 2013 ] - WOPRAI
Alcatel Lucent SA (NYSE:ALU), Down By 30.00% ($0. .. NET Report Predicted Stock Would Go Down Due To B
[ Thu, Jan 03rd 2013 ] - WOPRAI
VIG, SA, PRKR Are Seasonally Ripe To Go Down In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - WOPRAI
FXE, TRMK, STFC, RGC, CTRP, BCA Are Seasonally Ripe To Go Down In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - WOPRAI
DEF, TWC, FDL, BMTI, DHS, SATS Are Seasonally Ripe To Go Down In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - WOPRAI
GBNK, TAT, GRO, VEA, AXU, KALU Are Seasonally Ripe To Go Down In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - WOPRAI
RBS, ITM Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - WOPRAI
CRDC, CBLI, DUA, GLDD, SIRO, VRTU Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - WOPRAI
DMLP, GRH, BBNK, SIMO, ZUMZ, CTCT Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - WOPRAI
DLR, AMSWA, WLL, GLD, KTP, HOFT Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - WOPRAI
SNMX, AHT, VIA, HURC, DFS, WMAR Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Thu, Jan 03rd 2013 ] - Market Wire
Atossa Genetics to Present at OneMedForum and Biotech Showcase
[ Thu, Jan 03rd 2013 ] - WOPRAI
WWW, FAST, IBCA Expected To Be Up Before Next Earnings Releases
[ Thu, Jan 03rd 2013 ] - WOPRAI
TLAB, CRRC, SYBT Expected To Be Down Before Next Earnings Releases
[ Thu, Jan 03rd 2013 ] - WOPRAI
Blayne Curtis Downgraded (AMD) to Sell and Held Target at $2 on, Jan 3rd, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
PJ Juvekar Maintained (APD) at Hold with Increased Target to $91 on, Jan 3rd, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
Tycho Peterson Downgraded (WAT) to Hold and Held Target at $90 on, Jan 3rd, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
Steve Beuchaw Downgraded (WAT) to Hold on, Jan 3rd, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
Steven Chubak Maintained (C) at Strong Buy with Increased Target to $45 on, Jan 3rd, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
Lana Chan Downgraded (CATY) to Hold and Held Target at $21 on, Jan 3rd, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
Christopher Raymond Downgraded (BIIB) to Hold and Decreased Target to $166 on, Jan 3rd, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
Jay Olson Maintained (BIIB) at Hold with Decreased Target to $141 on, Jan 3rd, 2013
[ Thu, Jan 03rd 2013 ] - WOPRAI
Sumant Kulkarni Maintained (BIIB) at Hold with Decreased Target to $139 on, Jan 3rd, 2013

Sumant Kulkarni Maintained (BIIB) at Hold with Decreased Target to $139 on, Jan 3rd, 2013


Published on 2024-10-25 01:22:04 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $144 to $139 on, Jan 3rd, 2013.

Sumant has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Sumant's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Sumant

  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012
Contributing Sources